CJC-1295 without DAC

A modified 29-amino-acid GHRH fragment, often called CJC-1295 without DAC, designed for research on short-acting GHRH-receptor signalling.

In laboratory research, Modified GRF (1-29) (CJC-1295 without DAC) is primarily examined in relation to GHRH-receptor signalling, pituitary growth-hormone release and short-acting peptide pharmacology. The strength and type of evidence vary by compound and may be limited to mechanistic, cell-culture or animal studies.

Research note: This content is informational and describes laboratory research only. It does not provide human or veterinary dosing, treatment or administration guidance.